Carotenoids and chronic diseases

Drug Metabolism and Drug Interactions

Volumn 17, Issue 1-4, 2000, Pages 189-210

  Agarwal, S ^a   Rao, A V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer; Cardiovascular disease; Carotenoids; Diet; Lycopene; Oxidation; Prevention; Tomato

Indexed keywords

ALPHA CAROTENE; ANTIOXIDANT; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; CELL DNA; LOW DENSITY LIPOPROTEIN; LYCOPENE; REACTIVE OXYGEN METABOLITE; RETINOL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; XANTHOPHYLL;

CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL TRIAL; COOKING; CORONARY RISK; DIET SUPPLEMENTATION; DIET THERAPY; DRUG ABSORPTION; DRUG METABOLISM; FOOD COMPOSITION; FRUIT; HUMAN; ISOMERISM; LIPID OXIDATION; LIPOPROTEIN METABOLISM; LUNG CANCER; NONHUMAN; NUTRITIONAL REQUIREMENT; OXIDATIVE STRESS; REVIEW; RISK MANAGEMENT; STEREOCHEMISTRY; TOMATO; VEGETABLE;

EID: 0034519403     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2000.17.1-4.189     Document Type: Review

References (97)

1. Introduction: Nutrition and cancer
2. Causes and prevention of cancer
3. Free radicals and antioxidants in human disease
4. Protein oxidation and aging
5. The oxidation hypothesis of atherosclerosis
6. Oxidants, antioxidants and the degenerative diseases of aging
7. Free radicals and antioxidants in food and in vivo: What they do and how they work
8. Free radicals, antioxidants and human disease: Curiosity, cause or consequence?
9. Cancer prevention: Optimizing life-styles with special reference to nutritional carcinogenesis
10. A large scale cohort study on cancer risk by diet with special reference to the risk reducing effects of green-yellow vegetable consumption
11. Soy intake and cancer risk: A review of the in vitro and in vivo data
12. DNA lesions, inducible DNA repair, and cell division: Three key factors in mutagenesis and carcinogenesis
13. Cancer risk and oxidative DNA damage in man
14. Mitochondrial DNA mutations in human degenerative diseases and aging
15. Activation of oncogenes and/or inactivation of anti-oncogene by reactive oxygen species
16. Modulation of transcription factor NF6B binding activity by oxidation-reduction in vitro
17. Oncogene conversion of Ets affects redox regulation in vivo and in vitro
18. Redox modulation of p53 conformation and sequence-specific DNA binding
19. Evidence of lipid peroxidation in premenopausal women with mammographic dysplasia
20. Plasma lipids, lipoproteins, and mammographic densities
21. DNA oxidative damage and life expectancy in houseflies
22. Protein oxidative damage is associated with life expectancy of houseflies
23. Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans-retinoic acid in patients with advanced cancer
24. Prognostic and etiologic relevance of 8-hydroxyguanosine in human breast carcinogenesis
25. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues
26. β-Carotene and other carotenoids as antioxidants
27. Food carotenoids and cancer prevention: An overview of current research
28. The potential role of lycopene for human health
29. Structure and properties of carotenoids in relation to function
30. Carotenoids in fruits and vegetables: An evaluation of analytical data
31. Development and evaluation of an HPLC method for the analysis of carotenoids in foods, and the measurement of the carotenoid content of vegetables and fruits commonly consumed in the UK
32. Processing of fruits and vegetables: Effect on carotenoids
33. Absorption and transport of carotenoids
34. Absorption, metabolism and transport of carotenoids
35. Bioavailability of carotenoids
36. Lycopene is more bioavailable from tomato paste than from fresh tomatoes
37. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat
38. Carotenoids and gene regulation
39. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature
40. Beta-carotene and the carotenoids: Beyond the intervention trials
41. Dietary carotenoids and lung cancer: A review of recent research
42. Antioxidants in cardiovascular disease: Randomized trials
43. The effects of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
44. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
45. Lycopene: Chemical and biological properties
46. Lycopene: A biologically important carotenoid for humans?
47. Antioxidant activities of carotenes and xanthophylls
48. Relative stability of carotenoid radical cations and homologue tocopheroxyl radicals. A real time kinetic study of antioxidant hierarchy
49. Oxidation of carotenoids by free radicals: Relationship between structure and reactivity
50. Lycopene as the most effective biological carotenoid singlet oxygen quencher
51. Prolycopene, a naturally occurring stereoisomer of lycopene
52. Lycopene contents of tomatoes and tomato products and their contribution to dietary lycopene
53. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans
54. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: A review
55. Ingestion by men of a combined dose of β-carotene and lycopene does not affect the absorption of β-carotene but improves that of lycopene
56. Effect of diet and smoking on serum lycopene and lipid peroxidation
57. Cis-trans isomers of lycopene and β-carotene in human serum and tissues
58. Carotenoid composition, concentrations and relationships in various human organs
59. Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue
60. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples
61. The effect of dietary lycopene on bioavailability, tissue distribution, in-vivo antioxidant properties and colonic preneoplasia in rats
62. Cis-trans lycopene isomers, carotenoids and retinol in the human prostate
63. Intake of carotenoids and retinol in relation to risk of prostate cancer
64. Elevation of serum carotenoids after continual ingestion of tomato juice
65. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: A case control study
66. Modification of X-irradiation syndrome by lycopene
67. The promoting effects of lycopene on the non-specific resistance of animals
68. Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene
69. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice
70. Effects of lycopene-enriched tomato oleoresin on 7,12-dimethyl-benz[a]anthracene-induced rat mammary tumors
71. Inhibitory effect of tomato juice on rat urinary bladder carcinogenesis after N-butyl-N-(4-hydroybutyl)nitrosamine initiation
72. Prevention of N-methyl-nitrosourea-induced colon carcinogenesis in F344 rats by lycopene
73. Mediterranean epidemiological evidence on tomatoes and the prevention of digestive tract cancers
74. Tomatoes and risk of digestive-tract cancers
75. Increased green and yellow vegetables intake and lowered cancer death in an elderly population
76. Relationship of serum carotenoids, retinol, α-tocopherol, and selenium with breast cancer risk: Results from a prospective study in Columbia, Missouri (United States)
77. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis
78. Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study
79. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer
80. Consumption of vegetables reduces genetic damage in humans: First result of a human intervention trial with carotenoid-rich foods
81. Lycopene supplementation in men with prostate cancer (Pca) reduces grade and of preneoplasia (PIN) and tumor, decreases serum prostate specific antigen and modulates biomarkers of growth and differentiation
82. The role of oxidized low-density lipoproteins in pathogenesis of atherosclerosis
83. LDL oxidation: Therapeutic perspectives
84. Mechanism by which dietary antioxidants may prevent cardiovascular diseases
85. Serum carotenoids and coronary heart disease: The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study
86. Vitamin E consumption and the risk of coronary heart disease in men
87. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis
88. Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease
89. Lycopene and myocardial infarction risk in the EURAMIC study
90. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: Concomitant cross sectional study of men aged 50
91. Effect of a single dose of antioxidant mixture (vitamin E, carotenoids) on the formation of cholesterol oxidation products after ex-vivo LDL oxidation in humans
92. Hypocholesterolemic effect of lycopene and βcarotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophage
93. Micronutrients in HIV-infected women
94. Micronutrient levels in HIV-1-infected children
95. Serum antioxidants and age-related macular degeneration in a population-based case-control study
96. Risk factors for microangiopathy-related cerebral damage in Austrian stroke prevention study
97. Carotenoid levels in normal children and in children with cystic fibrosis